A bit more in depth look at the Moderna FDA data.
1. 94% effective at preventing COVID-19
That matches the earlier data and public statements
fda.gov/media/144434/d…
(1/6)
1. 94% effective at preventing COVID-19
That matches the earlier data and public statements
fda.gov/media/144434/d…
(1/6)
2. Prevents severe COVID-19
Zero cases in the vaccinated group. 30 severe cases of COVID-19 in the placebo group.
(2/6)
Zero cases in the vaccinated group. 30 severe cases of COVID-19 in the placebo group.
(2/6)
3. Worked the same in older adults and other subgroups
That matches the earlier data and public statements.
(3/6)
That matches the earlier data and public statements.
(3/6)
4. Evidence of prevention of asymptomatic infections.
This is interesting. The study was not designed to test this, but they had swab tests scheduled for the day of the second immunization. And there were substantially fewer asymptomatic infections in the vaccinated people. (4/6
This is interesting. The study was not designed to test this, but they had swab tests scheduled for the day of the second immunization. And there were substantially fewer asymptomatic infections in the vaccinated people. (4/6
It will be important to gather A LOT more data about asymptomatic infections to understand how well the vaccines prevent transmission, but it is encouraging to see this effect, and encouraging to see it so early after the 1st immunization. (5/6)
fda.gov/media/144453/d…
fda.gov/media/144453/d…
(This kind of data on asymptomatic infections is a lot more expensive to gather that symptomatic infections, because people have to be tested for virus repeatedly throughout a study. So it wasn't part of the main Pfizer and Moderna Phase 3 trials) (6/6)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
